Cowealth Medical China Co.,Ltd. (SHA:603122)

Market Cap	7.31B +179.5%
Revenue (ttm)	777.03M -19.9%
Net Income	-11.37M
EPS	-0.03
Shares Out	398.05M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.13 (0.71%)
Ex-Dividend Date	Jul 14, 2025

Volume	15,895,700
Average Volume	34,614,688
Open	17.94
Previous Close	17.80
Day's Range	17.50 - 18.08
52-Week Range	5.56 - 31.22
Beta	0.27
RSI	42.01
Earnings Date	Mar 14, 2026

About Cowealth Medical China

Cowealth Medical China Co.,Ltd. operates as a medical company in China. It offers management services for in-vitro diagnostic reagents and consumables; platform for decision-making and analysis, commercialization of achievements in medical science and technology; a multi-channel coaxial time audio video imaging platform; and an AI-assisted system for clinical diagnosis. The company was founded in 1997 and is based in Shanghai, China.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1997
• Employees: 203
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603122

Financial Performance

In 2024, Cowealth Medical China's revenue was 939.14 million, a decrease of -14.05% compared to the previous year's 1.09 billion. Earnings were 27.57 million, a decrease of -41.58%.